Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 8, CH-3010, Bern, Switzerland.
Institute of Diagnostic and Interventional Neuroradiology, Institute of Diagnostic, Interventional and Pediatric Radiology and Department of Neurology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland.
BMC Neurol. 2020 Mar 11;20(1):86. doi: 10.1186/s12883-020-01678-4.
Despite the utility of neuroimaging in the diagnostic and therapeutic management of patients with acute ischemic stroke (AIS), imaging characteristics in patients with preceding direct oral anticoagulants (DOAC) compared to vitamin K antagonists (VKA) have hardly been described. We aimed to determine presence of large vessel occlusion (LVO), thrombus length, infarction diameter, and occurrence of hemorrhagic transformation in AIS patients with preceding DOAC as compared to VKA therapy.
Using a prospectively collected cohort of AIS patients, we performed univariate and multivariable regression analyses regarding imaging outcomes. Additionally, we provide a sensitivity analysis for the subgroup of patients with confirmed therapeutic anticoagulation.
We included AIS in patients with preceding DOAC (N = 75) and VKA (N = 61) therapy, median age 79 (IQR 70-83), 39% female. Presence of any LVO between DOAC and VKA patients (29.3% versus 37.7%, P = 0.361), and target LVO for endovascular therapy (26.7% versus 27.9%, P = 1.0) was equal with a similar occlusion pattern. DOAC as compared to VKA were associated with a similar rate of target LVO for EVT (aOR 0.835, 95% CI 0.368-1.898). The presence of multiple lesions and characteristics of the thrombus were similar in DOAC and VKA patients. Acute ischemic lesion diameter in real world patients was equal in patients taking DOAC as compared to VKA. Lesion diameter in VKA patients (median 13 mm, IQR 6-26 versus median 20 mm, IQR 7-36, P = 0.001), but not DOAC patients was smaller in the setting of confirmed therapeutic VKA. The frequency of radiological hemorrhagic transformation and symptomatic intracranial hemorrhage in OAC patients was low. Sensitivity analysis considering only patients with confirmed therapeutic anticoagulation did not change any of the results.
Preceding DOAC treatment showed equal rates of LVO and infarct size as compared to VKA in AIS patients. This study adds to the knowledge of imaging findings in AIS patients with preceding anticoagulation.
尽管神经影像学在急性缺血性脑卒中(AIS)患者的诊断和治疗管理中具有重要作用,但与维生素 K 拮抗剂(VKA)相比,直接口服抗凝剂(DOAC)治疗的患者的影像学特征几乎没有被描述。我们旨在确定与 VKA 治疗相比,DOAC 治疗的 AIS 患者的大血管闭塞(LVO)、血栓长度、梗死直径和出血性转化的发生率。
我们使用前瞻性收集的 AIS 患者队列,进行了关于影像学结果的单变量和多变量回归分析。此外,我们还对经证实的治疗性抗凝亚组进行了敏感性分析。
我们纳入了 DOAC(N=75)和 VKA(N=61)治疗的 AIS 患者,中位年龄为 79 岁(IQR 70-83),39%为女性。DOAC 和 VKA 患者之间存在任何 LVO 的比例相同(29.3%与 37.7%,P=0.361),并且血管内治疗的目标 LVO 也相同(26.7%与 27.9%,P=1.0),闭塞模式相似。与 VKA 相比,DOAC 与接受 EVT 的目标 LVO 发生率相似(aOR 0.835,95%CI 0.368-1.898)。DOAC 和 VKA 患者的多个病变和血栓特征相似。在现实世界的患者中,服用 DOAC 与服用 VKA 的急性缺血性病变直径相等。VKA 患者的病变直径(中位数 13mm,IQR 6-26 与中位数 20mm,IQR 7-36,P=0.001),而不是 DOAC 患者的病变直径在确认治疗性 VKA 时较小。OAC 患者的放射学出血性转化和症状性颅内出血的频率较低。仅考虑接受确认治疗性抗凝治疗的患者的敏感性分析并未改变任何结果。
与 VKA 相比,DOAC 治疗的 AIS 患者的 LVO 和梗死面积发生率相等。本研究增加了抗凝治疗前 AIS 患者影像学表现的知识。